No. 43537 (5-year Review): Rule R384-203. Prescription Drug Database Access

DAR File No.: 43537
Filed: 02/25/2019 08:41:26 AM

NOTICE OF REVIEW AND STATEMENT OF CONTINUATION

Concise explanation of the particular statutory provisions under which the rule is enacted and how these provisions authorize or require the rule:

Subsection 58-37f-301(2)(f) establishes procedure and application process for Utah Department of Health Executive Director to designate and assign a person, who is not an employee of the Department of Health, to conduct scientific studies regarding the use or abuse of controlled substances.

Summary of written comments received during and since the last five-year review of the rule from interested persons supporting or opposing the rule:

No comments were received during and since the last five-year review of this rule from interested persons supporting or opposing this rule.

Reasoned justification for continuation of the rule, including reasons why the agency disagrees with comments in opposition to the rule, if any:

This rule is required by Subsection 58-37f-301(2)(f). Therefore, this rule should be continued.

The full text of this rule may be inspected, during regular business hours, at the Office of Administrative Rules, or at:

Health
Disease Control and Prevention, Health Promotion
CANNON HEALTH BLDG
288 N 1460 W
SALT LAKE CITY, UT 84116-3231

Direct questions regarding this rule to:

• Anna Fondario at the above address, by phone at 801-538-6201, by FAX at , or by Internet E-mail at [e-mail]

Effective:

02/25/2019

Authorized by:

Joseph Miner, Executive Director

---